[ LogicBio Therapeutics raises $45M in Series B funding ]
LogicBio Therapeutics has raised $45 million in Series B funding.
Founded in 2014, LogicBio Therapeutics is a biotechnology company that develops gene therapy and genome editing for the treatment of genetic diseases.
The company will use the fresh financing to advance gene therapies targeting orphan paediatric disorders through clinical trials.
|City||Foster City, California|
|Founder / CEO||Frederic Chereau|
|OrbiMed Israel Partners|
|SBI Japan-Israel Innovation Fund|
|Edmond de Rothschild Investment Partners|